It was once thought that Ebola and related filoviruses were more or less contained to Central Africa. After a West African outbreak and the discovery of Reston ebolavirus in the Philippines, ...

The virus that causes Ebola is well understood but puzzling issues remain on topics such as the disease's lethality and whether the virus can be stopped To much of the world, the virus behind the ...

Our public health strategy tends to be reactionary rather than preventative. Thus, instead of focusing most of our efforts in preparation for what is coming next, we are dumping limited resources on ...

Filoviruses, first recognized in 1967, usually infect bats but can also be transmitted to humans. While filoviruses do not usually manifest symptoms in infected bats, they have the potential to ...

BUFFALO, N.Y. — A new study is helping to rewrite Ebola’s family history. The research shows that filoviruses — a family to which Ebola and its similarly lethal relative, Marburg, belong — are at ...

Currently, there is no way to treat patients exposed to the Ebola or Marburg viruses or to prevent the diseases. Attempts at developing a vaccine are decades old, beginning in 1976 with the first ...

In a recent Pathogens review article, researchers discuss the development and structural characterization of therapeutic monoclonal antibodies targeting the surface glycoprotein of filoviruses, ...

Scientists turn nanoparticles into virus 'showcases' to help the immune system recognize deadly threats. (Nanowerk News) Filoviruses get their name from the Latin word “filum,” meaning thread—a ...

The Junin vaccine (also known as candid #1) is the only one that has been developed for protection against a viral hemorrhagic fever. This live attenuated vaccine against the Junin virus (the cause of ...

An illustration of a self-assembling protein nanoparticle (SApNP) displaying Ebola virus surface proteins. This vaccine strategy is designed to help the immune system more effectively and respond to ...